Garrison Asset Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Garrison Asset Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2022$237,000
-17.1%
3,6870.0%0.16%
-1.2%
Q1 2022$286,000
-9.5%
3,687
+0.0%
0.16%
-6.4%
Q4 2021$316,000
+2.9%
3,686
-3.5%
0.17%
-7.5%
Q3 2021$307,000
+3.4%
3,821
+3.4%
0.19%
+3.3%
Q2 2021$297,000
-5.7%
3,695
-1.2%
0.18%
-10.0%
Q1 2021$315,000
+5.0%
3,7400.0%0.20%
-2.9%
Q4 2020$300,000
-19.6%
3,740
-19.4%
0.21%
+4.6%
Q3 2020$373,000
-6.5%
4,6400.0%0.20%
-12.1%
Q2 2020$399,000
+4.5%
4,640
-1.3%
0.22%
-13.2%
Q1 2020$382,000
-4.0%
4,700
-1.2%
0.26%
+31.6%
Q4 2019$398,000
-4.8%
4,759
-0.4%
0.20%
-9.7%
Q3 2019$418,000
+6.9%
4,7790.0%0.22%
+6.9%
Q2 2019$391,000
+0.5%
4,779
+0.0%
0.20%
-1.5%
Q1 2019$389,000
+17.9%
4,778
-4.6%
0.21%
+5.6%
Q4 2018$330,000
-14.5%
5,0080.0%0.20%
+2.1%
Q3 2018$386,000
-7.9%
5,008
-11.8%
0.19%
-9.5%
Q2 2018$419,000
+13.6%
5,6770.0%0.21%
+2.4%
Q1 2018$369,000
+0.5%
5,6770.0%0.21%
+7.3%
Q4 2017$367,000
+3.1%
5,6770.0%0.19%
-4.0%
Q3 2017$356,000
+3.5%
5,677
+0.0%
0.20%0.0%
Q2 2017$344,000
+16.2%
5,676
-0.7%
0.20%
+14.9%
Q1 2017$296,000
+16.5%
5,716
-0.4%
0.17%
+10.1%
Q4 2016$254,000
-7.0%
5,7390.0%0.16%
-9.7%
Q3 2016$273,000
+12.3%
5,739
+6.6%
0.18%
+8.0%
Q2 2016$243,000
+10.0%
5,3840.0%0.16%
+4.5%
Q1 2016$221,000
+7.8%
5,3840.0%0.16%
+9.9%
Q4 2015$205,000
-33.9%
5,384
+21.6%
0.14%
-32.2%
Q2 2015$310,000
-1.3%
4,426
-3.6%
0.21%0.0%
Q1 2015$314,0004,5910.21%
Other shareholders
BAXTER INTL INC shareholders Q4 2016
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders